SCANDIDERMA AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−5,2 mill kr).
SCANDIDERMA AS is registered as a limited company in Tromsø, Troms with organisation number 895238902. The business is classified under manufacture of basic pharmaceutical products (NACE 21.100). The company was incorporated in 2010. Registered share capital is NOK 241,000, divided into 241149 shares. The company's stated purpose is: “Utvikle, produsere og selge kosmetiske ingredienser, samt engasjere seg i det som står i naturlig sammenheng med dette. Selskapet skal også kunne delta i andre selskaper med lignende økonomisk formål.”. The most recent filed accounts, for the 2025 financial year, show NOK 927,000 in revenue and NOK 835,000 in operating profit.
Former names: SCANDINAVIAN DERMAL INNOVATIONS AS
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns SCANDIDERMA AS?
SCANDIDERMA AS has 18 registered shareholders:
- GHK INVEST AS 35.2%
- KANDAL INVEST AS 19.2%
- SEEBERG HOLDING AS 14.2%
- IMPETO AS 6.0%
- MONTECRISTO INV. INTERNATIONAL 5.0%
- Ingmar Fimreite 4.1%
- JACEK BARTOSIK 4.1%
- R3 HOLDING AS 2.1%
- DRUG DISCOVERY LABORATORY AS 2.1%
- LAVOLD INVEST AS 2.1%
- Arild Rune Klakegg 1.9%
- FIMREITE AS 1.2%
- Remi Lunde Solbakken 0.9%
- Arthur Andersen Knutsen 0.6%
- Bård Stian Nybø 0.6%
- Daniel Eriksen Martinsen 0.3%
- Christoffer Ryan 0.3%
- KLAKEGG HOLDING AS 0.2%
Frequently asked questions about SCANDIDERMA AS
Who owns SCANDIDERMA AS?
GHK INVEST AS is the largest registered owner, with 35.2%.
What is the revenue of SCANDIDERMA AS?
SCANDIDERMA AS had revenue of NOK 927,000 in 2025.
Who is the general manager of SCANDIDERMA AS?
Geir Håvard Kvalheim is registered as general manager of SCANDIDERMA AS.
Where is SCANDIDERMA AS based?
SCANDIDERMA AS has its business address in Tromsø.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.